Hims Reports Sales Shortfall Amid Rising Telehealth Competition
Hims & Hers, a leading telehealth company, reported a sales miss as competition in the digital health space intensifies. The company's financial resul...
Xeber.world
biotech
- electric vehicles
- automotive industry
- Stellantis
- collector cars
- automotive history
- Limited Edition
- classic cars
- Mecum Auctions
- supercar
- Formula 1
- Donald Trump
- AI ethics
- U.S. China relations
- AI adoption
- AI regulation
- artificial intelligence
- Trump administration
- inflation
- AI governance
- AI in business
- Bitcoin
- crypto regulation
- Senate Banking Committee
- CLARITY Act
- digital assets
- Digital Asset Market Clarity Act
- Federal Reserve
- Bitcoin price
- Bitcoin ETF
- crypto market
- AI cybersecurity
- cybersecurity
- CISA
- enterprise security
- CVE-2026-41089
- CVE-2026-41096
- Canvas data breach
- Instructure
- House Homeland Security Committee
- Donald Trump
- Netflix
- late-night TV
- Disney
- Paramount
- Cannes Film Festival
- Stephen Colbert
- Prime Video
- Jimmy Kimmel
- Marvel
- climate change
- renewable energy
- energy policy
- AI data centers
- geothermal energy
- Fervo Energy
- U.S. energy policy
- Strait of Hormuz
- Jason Bordoff
- Texas drought
- Subnautica 2
- Phasmophobia
- gaming news
- R.E.P.O.
- Forza Horizon 6
- FC 26
- Subnautica 2 tips
- Subnautica 2 guide
- Alan Wake event
- Destructoid
- FDA
- public health
- Marty Makary
- Trump administration
- healthcare policy
- Kyle Diamantas
- hantavirus
- health policy
- FDA leadership
- gene therapy
- Donald Trump
- Trump administration
- Supreme Court
- gerrymandering
- Iran war
- Voting Rights Act
- 2024 election
- Republican Party
- Virginia Supreme Court
- redistricting
- AI ethics
- climate change
- Elon Musk
- OpenAI
- ChatGPT
- tech industry
- Tesla
- remote sensing
- AI in the workplace
- generative AI
Biotech Firms Dress for the Met Gala: A Playful Blend of Fashion and Pharma
STAT’s biotech newsletter, The Readout, turns the Met Gala into a creative showcase by reimagining biopharma logos as high-fashion outfits. This annua...
Seaport Therapeutics CEO Discusses IPO Success on 400th Episode of Biotech Podcast
Seaport Therapeutics CEO Daphne Zohar joins the 400th episode of 'The Readout LOUD' to discuss the biotech's successful IPO. The episode also covers t...
Analysts Overlook Lilly’s Liver Concerns Too Quickly, Experts Question Risk Assessment
Vertex Pharma halts early-stage mRNA cystic fibrosis therapy VX-522 due to tolerability issues. Cytokinetics’ Myqorzo meets dual efficacy goals in gen...
Mother of Girl Who Received Bespoke Gene Therapy Launches New Biotech to Scale Treatments
Julia Vitarello, whose daughter Mila received a custom gene therapy eight years ago, is launching a new biotech to scale bespoke treatments. Her previ...
Investors Bet Big on Hair Loss Drugs: AI in Trials & Pharma M&A Insights from STAT+ Podcast
Investors are flocking to hair loss treatments, AI is transforming clinical trials, and a nonprofit pharma firm makes bold M&A moves. STAT+ unpacks th...
Pfizer and BridgeBio Secure Patent Win: Key Biotech Developments Today
Italian pharma giant Chiesi acquires KalVista Therapeutics for $1.9 billion, adding a rare-disease treatment to its portfolio. Meanwhile, major biotec...
Boehringer’s Obesity Drug Achieves 16.6% Weight Loss in Trial; Further Data Pending
Boehringer’s investigational obesity drug demonstrated a 16.6% weight loss in a clinical trial, outperforming many existing treatments. However, addit...
Sanofi's Research Priorities Under Scrutiny as New CEO Belén Garijo Takes Charge
Sanofi's research priorities are under review as new CEO Belén Garijo begins her tenure. The company's recent focus on immunology has yielded lacklust...